Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 29% ± 9% | |
| oligodendrocyte precursor cell | 6 studies | 34% ± 13% | |
| macrophage | 5 studies | 30% ± 6% | |
| epithelial cell | 4 studies | 28% ± 9% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| plasma cell | 3 studies | 17% ± 1% | |
| hepatocyte | 3 studies | 39% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 30% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1970.07 | 459 / 459 | 98% | 16.93 | 1101 / 1118 |
| prostate | 99% | 3178.73 | 243 / 245 | 99% | 14.76 | 498 / 502 |
| ovary | 99% | 1742.99 | 179 / 180 | 98% | 10.75 | 420 / 430 |
| liver | 100% | 2691.40 | 226 / 226 | 97% | 9.69 | 393 / 406 |
| thymus | 100% | 4625.04 | 653 / 653 | 95% | 26.85 | 573 / 605 |
| lung | 99% | 1503.48 | 573 / 578 | 95% | 11.71 | 1099 / 1155 |
| skin | 98% | 3767.24 | 1772 / 1809 | 96% | 13.37 | 451 / 472 |
| kidney | 100% | 2333.66 | 89 / 89 | 93% | 13.45 | 835 / 901 |
| brain | 96% | 1096.98 | 2530 / 2642 | 96% | 9.08 | 679 / 705 |
| stomach | 93% | 3305.99 | 333 / 359 | 99% | 15.13 | 283 / 286 |
| intestine | 86% | 1762.46 | 835 / 966 | 99% | 14.44 | 520 / 527 |
| bladder | 90% | 2976.95 | 19 / 21 | 93% | 22.35 | 471 / 504 |
| esophagus | 87% | 1689.07 | 1251 / 1445 | 96% | 12.86 | 175 / 183 |
| uterus | 90% | 1033.10 | 153 / 170 | 89% | 12.32 | 408 / 459 |
| pancreas | 81% | 669.87 | 267 / 328 | 94% | 11.50 | 168 / 178 |
| adrenal gland | 94% | 1153.07 | 243 / 258 | 76% | 17.04 | 175 / 230 |
| eye | 0% | 0 | 0 / 0 | 100% | 19.92 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.21 | 29 / 29 |
| spleen | 100% | 1874.04 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.30 | 1 / 1 |
| adipose | 99% | 1610.36 | 1191 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 17.47 | 44 / 45 |
| muscle | 97% | 1520.71 | 782 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 97% | 1420.56 | 1295 / 1335 | 0% | 0 | 0 / 0 |
| heart | 85% | 774.11 | 736 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 50% | 1034.15 | 465 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007528 | Biological process | neuromuscular junction development |
| GO_0005615 | Cellular component | extracellular space |
| GO_0048786 | Cellular component | presynaptic active zone |
| GO_0005829 | Cellular component | cytosol |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | PPFIBP2 |
| Protein name | PPFIA binding protein 2 Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2) (PTPRF-interacting protein-binding protein 2) |
| Synonyms | |
| Description | FUNCTION: May regulate the disassembly of focal adhesions. Did not bind receptor-like tyrosine phosphatases type 2A. . |
| Accessions | ENST00000650027.1 ENST00000529575.5 ENST00000684215.1 ENST00000533792.5 E9PMH3 E9PI79 A0A804HKA2 Q8ND30 E9PIK8 ENST00000534552.1 ENST00000526873.5 H0YDM0 E9PMN3 ENST00000530181.5 [Q8ND30-3] E9PP16 H0YDJ2 ENST00000526046.1 ENST00000524548.5 A0A3B3IS15 ENST00000299492.9 [Q8ND30-1] ENST00000528883.5 [Q8ND30-2] ENST00000525597.5 E9PK17 ENST00000528947.5 H0YET1 E9PJA0 ENST00000534409.5 ENST00000684123.1 A0A804HJY3 ENST00000527790.5 ENST00000530081.1 |
